Lamocent-DT 100 Tablet contains Lamotrigine 100 mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes through inhibition of voltage-sensitive sodium channels, thereby modulating the release of excitatory neurotransmitters such as glutamate and aspartate. This mechanism helps in reducing the frequency and severity of seizures in patients with partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is effective in the maintenance treatment of bipolar disorder, particularly in delaying the occurrence of mood episodes, including depression and mania. Lamocent-DT 100 Tablet is designed as a dispersible tablet, facilitating ease of administration, especially for patients with swallowing difficulties. It is important to initiate treatment at a low dose and titrate gradually to minimize the risk of serious skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Regular monitoring and adherence to prescribed dosing schedules are essential to optimize therapeutic outcomes and minimize adverse effects. Lamocent-DT 100 should be used under strict medical supervision, with caution advised in patients with hepatic or renal impairment and those on concomitant medications that may interact with Lamotrigine.